SCHEMBL4190726

SCHEMBL4190726

C[C@@H](CC1CCCCCC1)NCc1ccccc1NS(=O)(=O)c1ccc(-n2ccnc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
PKM P14618 1/20 0.46
LMNA P02545 4/20 0.39
POLB P06746 2/20 0.39
MTOR P42345 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
ALDH1A1 P00352 8/20 0.38
MAPT P10636 6/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TDP1 Q9NUW8 1/20 0.37
MCHR1 Q99705 1/20 0.36
CHRNA7 P36544 1/20 0.36
MEN1 O00255 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4194128 1.00 KDM4E (0.46) KDM4EPKMLMNAPOLBMTOR
SCHEMBL27725824 1.00 KDM4E (0.46) KDM4EPKMLMNAPOLBMTOR
SCHEMBL4196860 0.99 KDM4E (0.44) KDM4EPKMLMNAPOLBMTOR
SCHEMBL4202288 0.89 PKM (0.50) KDM4EPKMLMNAPOLBALDH1A1
SCHEMBL4200151 0.88 KDM4E (0.41) KDM4EPKMLMNAPOLBMTOR
SCHEMBL4201917 0.88 PKM (0.48) KDM4EPKMLMNAPOLBALDH1A1
SCHEMBL4197301 0.87 KDM4E (0.40) KDM4EPKMLMNAPOLBMTOR
SCHEMBL4190554 0.87 KDM4E (0.40) KDM4EPKMLMNAPOLBALDH1A1
SCHEMBL4189861 0.85 KMT2A (0.53) KDM4EPKMLMNAPOLBALDH1A1
SCHEMBL4193489 0.84 KDM4E (0.46) KDM4EPKMLMNAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 KDM4E 3328/4885PKM 1855/4885LMNA 2332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.